Europe Dermal Fillers Market
完整報告名稱與涵蓋範圍
Europe Dermal Fillers Market Research Research Report - Forecast to 2032
報告摘要
Europe Dermal Fillers Market Research Report Forecast to 2032
Market Overview
Dermal filler is a gel-like substance that is injected underneath the skin to restore lost volume, often creases and smooth lines or enhance facial contours. Dermal fillers usage has rapidly grown in recent years because of various offerings in the enhancing aesthetic and rejuvenate improvements that were previously only achievable with surgeries. These are becoming very popular for facial rejuvenation methods. Being minimally invasive dermal filler shows instantaneous results in cosmetic volume replacement therapies.
Dermal fillers can be defined as soft tissue fillers injected into the skin for the restoration of smooth appearance and the reduction of wrinkles and other signs of the aging process. The rapidly expanding range of dermal filler products and their increased benefits are fueling the preference rates of dermal fillers among medical professionals as well as patients. The growing demand for facial aesthetics, increasing inclination towards the use of dermal fillers, a rise in the number of plastic surgeons performing cosmetic surgeries, and the decreased procedural cost of dermal fillers in comparison to the cosmetic surgeries are driving the dermal fillers market. However, the side-effects associated with such facial injectables, coupled with the increasing black market for dermal fillers, and emergence of COVID-19 coronavirus is likely to curb the growth of the dermal fillers market. Nevertheless, the rise in the number of clinical trial studies for increasing efficiency rates of dermal fillers will create lucrative opportunities for the growth of the market during the assessment period.
Market Segmentation
Based on type, the Europe dermal fillers market has been segmented into botulinum toxin, calcium hydroxylapatite, hyaluronic acid, polyalkylimide, poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA), and others.
Based on product, the Europe dermal fillers market has been segmented into biodegradable, non-biodegradable, synthetic neurotoxins.
On the basis of application, the Europe dermal fillers market has been segmented into facial line correction, face lift, lip enhancement, facial scars, nasolabial folds, and others.
Based on country, the Europe dermal filler market has been segmented into Germany, France, UK, Italy, Spain, Denmark, Finland, Iceland, Norway, Sweden, and Rest of Europe. Germany accounted for the largest market share in 2022. However, France is projected to grow at fastest growing during the forecast period.
Major Players
The key market players are Merz Pharma GmbH & Co. KGaA, Sinclair Pharma, Ipsen SA (Ipsen), ADODERM GmbH, BioScience GmbH, Allergan Inc. (Allergan), Galderma develops aesthetics, Teoxane, Dr. Korman, and Medytox.
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 16
2 MARKET INTRODUCTION 18
2.1 DEFINITION 18
2.2 SCOPE OF THE STUDY 18
2.3 RESEARCH OBJECTIVE 18
2.4 MARKET STRUCTURE 19
3 RESEARCH METHODOLOGY 20
3.1 OVERVIEW 20
3.2 DATA FLOW 22
3.2.1 Data Mining Process 22
3.3 PURCHASED DATABASE: 23
3.4 SECONDARY SOURCES: 24
3.4.1 Secondary Research data flow: 25
3.5 PRIMARY RESEARCH: 26
3.5.1 Primary Research DATA FLOW: 27
3.5.2 Primary Research: Number of Interviews conducted 28
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 28
3.6.1 Revenue Analysis Approach 28
3.7 DATA FORECASTING 29
3.7.1 Data forecasting Technique 30
3.8 DATA MODELLING 31
3.8.1 microeconomic factor analysis: 31
3.8.2 Data Modelling: 32
3.9 TEAMS AND ANALYST CONTRIBUTION 34
4 MARKET DYNAMICS 36
4.1 INTRODUCTION 36
4.2 DRIVERS 36
4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS 36
4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS 37
4.2.3 Rapid advancements in technology 38
4.3 RESTRAINTS 38
4.3.1 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS 38
4.4 OPPORTUNITY 41
4.4.1 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 41
5 MARKET FACTOR ANALYSIS 42
5.1 PORTER’S FIVE FORCES MODEL 42
5.1.1 Threat of New Entrants 43
5.1.2 Bargaining Power of Suppliers 43
5.1.3 Threat of Substitutes 43
5.1.4 Bargaining Power of Buyers 43
5.1.5 Intensity of Rivalry 43
5.2 IMPACT OF COVID-19 ON THE EUROPE DERMAL FILLERS MARKET 44
5.2.1 impact on supply chain 44
5.2.2 IMPACT ON KEY PLAYERS 44
5.3 NUMBER OF DERMAL FILLER PROCEDURES, BY COUNTRY- 2019-2032 45
5.4 TOTAL NUMBER OF PRIVATE DERMATOLOGY CLINICS, BY COUNTRY (2022) 45
6 EUROPE DERMAL FILLERS MARKET, BY TYPE 47
6.1 OVERVIEW 47
6.2 BOTULINUM TOXIN 50
6.3 CALCIUM HYDROXYLAPATITE 52
6.4 HYALURONIC ACID 54
6.5 POLY-L-LACTIC ACID 56
6.6 POLYALKYLIMIDE 58
6.7 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) 60
6.8 OTHERS 62
7 EUROPE DERMAL FILLERS MARKET, BY PRODUCT 64
7.1 OVERVIEW 64
7.2 BIODEGRADABLE 66
7.3 NON-BIODEGRADABLE 67
7.4 SYNTHETIC NEUROTOXIN 68
8 EUROPE DERMAL FILLERS MARKET, BY APPLICATION 69
8.1 OVERVIEW 69
8.2 FACIAL LINE CORRECTION 72
8.3 FACE LIFT 73
8.4 LIP ENHANCEMENT 74
8.5 FACIAL SCARS 75
8.6 NASOLABIAL FOLDS 76
8.7 OTHERS 77
9 EUROPE DERMAL FILLERS MARKET, BY COUNTRY 78
9.1 OVERVIEW 78
9.2 EUROPE 78
9.2.1 Germany 81
9.2.2 France 82
9.2.3 United Kingdom 84
9.2.4 Spain 85
9.2.5 Italy 87
9.2.6 Denmark 88
9.2.7 Finland 90
9.2.8 Iceland 91
9.2.9 Norway 93
9.2.10 Sweden 95
9.2.11 Rest of Europe 97
10 COMPETITIVE LANDSCAPE 100
10.1 INTRODUCTION 100
10.2 COMPETITOR DASHBOARD 101
10.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 102
10.3.1 product launch 102
10.3.2 Agreement launch 102
11 COMPANY PROFILES 103
11.1 IPSEN SA 103
11.1.1 COMPANY OVERVIEW 103
11.1.2 FINANCIAL OVERVIEW 104
11.1.3 PRODUCTS OFFERED 104
11.1.4 KEY DEVELOPMENTS 105
11.1.5 SWOT ANALYSIS 105
11.1.6 KEY STRATEGIES 105
11.2 ADODERM GMBH 106
11.2.1 COMPANY OVERVIEW 106
11.2.2 FINANCIAL OVERVIEW 106
11.2.3 PRODUCTS OFFERED 107
11.2.4 KEY DEVELOPMENTS 107
11.2.5 KEY STRATEGIES 107
11.3 BIOSCIENCE GMBH 108
11.3.1 COMPANY OVERVIEW 108
11.3.2 FINANCIAL OVERVIEW 109
11.3.3 PRODUCTS OFFERED 109
11.3.4 KEY DEVELOPMENTS 109
11.3.5 KEY STRATEGIES 109
11.4 ALLERGAN, INC. 110
11.4.1 COMPANY OVERVIEW 110
11.4.2 FINANCIAL OVERVIEW 110
11.4.3 Products OFFERed 111
11.4.4 KEY DEVELOPMENTS 111
11.4.5 SWOT ANALYSIS 112
11.4.6 Key Strategy 112
11.5 MERZ PHARMA GMBH & CO. KGAA 113
11.5.1 COMPANY OVERVIEW 113
11.5.2 FINANCIAL OVERVIEW 113
11.5.3 PRODUCTS OFFERED 114
11.5.4 KEY DEVELOPMENTS 114
11.5.5 SWOT ANALYSIS 115
11.5.6 KEY STRATEGIES 115
11.6 GALDERMA 116
11.6.1 COMPANY OVERVIEW 116
11.6.2 FINANCIAL OVERVIEW 116
11.6.3 PRODUCTS OFFERED 117
11.6.4 KEY DEVELOPMENTS 117
11.6.5 SWOT ANALYSIS 118
11.6.6 KEY STRATEGIES 118
11.7 SINCLAIR PHARMA 119
11.7.1 COMPANY OVERVIEW 119
11.7.2 FINANCIAL OVERVIEW 119
11.7.3 PRODUCTS OFFERED 120
11.7.4 KEY DEVELOPMENTS 120
11.7.5 KEY STRATEGIES 120
11.8 TEOXANE 121
11.8.1 COMPANY OVERVIEW 121
11.8.2 FINANCIAL OVERVIEW 122
11.8.3 productS OFFERED 122
11.8.4 KEY DEVELOPMENTS 122
11.8.5 KEY STRATEGIES 122
11.9 DR. KORMAN 123
11.9.1 COMPANY OVERVIEW 123
11.9.2 FINANCIAL OVERVIEW 124
11.9.3 products OFFERED 124
11.9.4 KEY DEVELOPMENTS 124
11.9.5 KEY STRATEGIES 124
11.10 MEDYTOX 125
11.10.1 COMPANY OVERVIEW 125
11.10.2 FINANCIAL OVERVIEW 126
11.10.3 productS OFFERED 126
11.10.4 KEY DEVELOPMENTSs 126
11.10.5 SWOT ANALYSIS 127
11.10.6 KEY STRATEGIES 127
12 DATA CITATIONS 128
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT 32
TABLE 2 NUMBER OF DERMAL FILLER PROCEDURES, BY COUNTRY- 2019-2032 45
TABLE 3 TOTAL NUMBER OF PRIVATE DERMATOLOGY CLINICS, BY COUNTRY (2022) 45
TABLE 4 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (USD MILLION) 49
TABLE 5 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2019–2032 (NUMBER IN VOLUME) 49
TABLE 6 EUROPE DERMAL FILLERS MARKET, FOR BOTULINUM TOXIN, BY COUNTRY, 2019–2032 (USD MILLION) 50
TABLE 7 EUROPE DERMAL FILLERS MARKET, FOR BOTULINUM TOXIN, BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 51
TABLE 8 EUROPE DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY COUNTRY, 2019–2032 (USD MILLION) 52
TABLE 9 EUROPE DERMAL FILLERS MARKET, FOR CALCIUM HYDROXYLAPATITE, BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 53
TABLE 10 EUROPE DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY COUNTRY, 2019–2032 (USD MILLION) 54
TABLE 11 EUROPE DERMAL FILLERS MARKET, FOR HYALURONIC ACID, BY COUNTRY, 2019–2032 (N NUMBER OF PROCEDURE) 55
TABLE 12 EUROPE DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY COUNTRY, 2019–2032 (USD MILLION) 56
TABLE 13 EUROPE DERMAL FILLERS MARKET, FOR POLY-L-LACTIC ACID, BY COUNTRY, 2019–2032 (N NUMBER OF PROCEDURE) 57
TABLE 14 EUROPE DERMAL FILLERS MARKET, FOR POLYALKYLIMIDE, BY COUNTRY, 2019–2032 (USD MILLION) 58
TABLE 15 EUROPE DERMAL FILLERS MARKET, FOR POLYALKYLIMIDE, BY COUNTRY, 2019–2032 (N NUMBER OF PROCEDURE) 59
TABLE 16 EUROPE DERMAL FILLERS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY COUNTRY, 2019–2032 (USD MILLION) 60
TABLE 17 EUROPE DERMAL FILLERS MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 61
TABLE 18 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 62
TABLE 19 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (NUMBER OF PROCEDURE) 63
TABLE 20 EUROPE DERMAL FILLERS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 65
TABLE 21 EUROPE DERMAL FILLERS MARKET, FOR BIODEGRADABLE, BY COUNTRY, 2019–2032 (USD MILLION) 66
TABLE 22 EUROPE DERMAL FILLERS MARKET, FOR NON-BIODEGRADABLE, BY COUNTRY, 2019–2032 (USD MILLION) 67
TABLE 23 EUROPE DERMAL FILLERS MARKET, FOR SYNTHETIC NEUROTOXIN, BY COUNTRY, 2019–2032 (USD MILLION) 68
TABLE 24 EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 71
TABLE 25 EUROPE DERMAL FILLERS MARKET, FOR FACIAL LINE CORRECTION, BY COUNTRY, 2019–2032 (USD MILLION) 72
TABLE 26 EUROPE DERMAL FILLERS MARKET, FOR FACE LIFT, BY COUNTRY, 2019–2032 (USD MILLION) 73
TABLE 27 EUROPE DERMAL FILLERS MARKET, FOR LIP ENHANCEMENT, BY COUNTRY, 2019–2032 (USD MILLION) 74
TABLE 28 EUROPE DERMAL FILLERS MARKET, FOR FACIAL SCARS, BY COUNTRY, 2019–2032 (USD MILLION) 75
TABLE 29 EUROPE DERMAL FILLERS MARKET, FOR NASOLABIAL FOLDS, BY COUNTRY, 2019–2032 (USD MILLION) 76
TABLE 30 EUROPE DERMAL FILLERS MARKET, FOR OTHERS, BY COUNTRY, 2019–2032 (USD MILLION) 77
TABLE 31 EUROPE: EUROPE DERMAL FILLERS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 80
TABLE 32 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 81
TABLE 33 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 81
TABLE 34 GERMANY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 81
TABLE 35 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 82
TABLE 36 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 82
TABLE 37 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 83
TABLE 38 FRANCE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 83
TABLE 39 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 83
TABLE 40 UNITED KINGDOM: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 84
TABLE 41 UNITED KINGDOM: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 84
TABLE 42 UNITED KINGDOM: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 84
TABLE 43 UNITED KINGDOM: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 85
TABLE 44 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 85
TABLE 45 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 86
TABLE 46 SPAIN: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 86
TABLE 47 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 86
TABLE 48 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 87
TABLE 49 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 87
TABLE 50 ITALY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 87
TABLE 51 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 88
TABLE 52 DENMARK: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 88
TABLE 53 DENMARK: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 89
TABLE 54 DENMARK: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 89
TABLE 55 DENMARK: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 89
TABLE 56 FINLAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 90
TABLE 57 FINLAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 90
TABLE 58 FINLAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 90
TABLE 59 FINLAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 91
TABLE 60 ICELAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 91
TABLE 61 ICELAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 91
TABLE 62 ICELAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 92
TABLE 63 ICELAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 92
TABLE 64 NORWAY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 93
TABLE 65 NORWAY: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 93
TABLE 66 NORWAY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 94
TABLE 67 NORWAY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 94
TABLE 68 SWEDEN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 95
TABLE 69 SWEDEN: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 96
TABLE 70 SWEDEN: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 96
TABLE 71 SWEDEN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 96
TABLE 72 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (USD MILLION) 97
TABLE 73 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2030 (NUMBER OF PROCEDURES) 97
TABLE 74 REST OF EUROPE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 97
TABLE 75 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 98
TABLE 76 PRODUCT LAUNCH 102
TABLE 77 AGREEMENT LAUNCH 102
TABLE 78 IPSEN SA : PRODUCTS OFFERED 104
TABLE 79 IPSEN SA : SWOT ANALYSIS 105
TABLE 80 ADODERM GMBH: PRODUCTS OFFERED 107
TABLE 81 BIOSCIENCE GMBH: PRODCUTS OFFERED 109
TABLE 82 ALLERGAN, INC.: PRODUCTS OFFERED 111
TABLE 83 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS OFFERED 114
TABLE 84 MERZ PHARMA GMBH & CO. KGAA: KEY DEVELOPMENTS 114
TABLE 85 GALDERMA: PRODCUTS OFFERED 117
TABLE 86 SINCLAIR PHARMA: PRODUCTS OFFERED 120
TABLE 87 SINCLAIR PHARMA: KEY DEVELOPMENTS 120
TABLE 88 TEOXANE: PRODUCT OFFERED 122
TABLE 89 DR. KORMAN: PRODUCT OFFERED 124
TABLE 90 MEDYTOX: PRODUCT OFFERED 126
LIST OF FIGURES
FIGURE 1 EUROPE DERMAL FILLER MARKET: STRUCTURE 19
FIGURE 2 EUROPE DERMAL FILLERSMARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 36
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 38
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 39
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: EUROPE DERMAL FILLERS MARKET 42
FIGURE 6 EUROPE DERMAL FILLERS MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 48
FIGURE 7 EUROPE DERMAL FILLERS MARKET, BY TYPE, 2022 & 2032 (USD MILLION) 48
FIGURE 8 EUROPE DERMAL FILLERS MARKET SHARE (%), BY TYPE, 2022 50
FIGURE 9 EUROPE DERMAL FILLERS MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 64
FIGURE 10 EUROPE DERMAL FILLERS MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) 65
FIGURE 11 EUROPE DERMAL FILLERS MARKET SHARE (%), BY PRODUCT, 2022 65
FIGURE 12 EUROPE DERMAL FILLERS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 70
FIGURE 13 EUROPE DERMAL FILLERS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 70
FIGURE 14 EUROPE DERMAL FILLERS MARKET SHARE (%), BY APPLICATION, 2022 71
FIGURE 15 EUROPE MARKET ANALYSIS: DERMAL FILLERS MARKET, 2019-2032 (USD MILLION) 79
FIGURE 16 EUROPE: EUROPE DERMAL FILLERS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 79
FIGURE 17 EUROPE: EUROPE DERMAL FILLERS MARKET SHARE (%), BY COUNTRY, 2022 80
FIGURE 18 COMPETITOR DASHBOARD: EUROPE DERMAL FILLERS MARKET 101
FIGURE 19 IPSEN SA : FINANCIAL OVERVIEW SNAPSHOT 104
FIGURE 20 ALLERGAN, INC.: SWOT ANALYSIS 112
FIGURE 21 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS 115
FIGURE 22 GALDERMA: SWOT ANALYSIS 118
FIGURE 23 MEDYTOX: SWOT ANALYSIS 127
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們